Improved diagnostic markers for invasive pulmonary aspergillosis in COPD patients

Front Cell Infect Microbiol. 2024 Apr 3:14:1294971. doi: 10.3389/fcimb.2024.1294971. eCollection 2024.

Abstract

Background: The prevalence of invasive pulmonary aspergillosis (IPA) among patients with chronic obstructive pulmonary disease (COPD) is steadily increasing, leading to high mortality. Although early diagnosis can significantly reduce mortality, the efficacy of current diagnostic methods is limited. Consequently, there is a need for novel approaches for early IPA detection.

Methods: This retrospective study involved 383 hospitalized COPD patients with GOLD stages III and IV. The IPA group (67 patients) and non-IPA group (316 patients) were identified at the First Affiliated Hospital of Guangzhou Medical University between January 2016 and February 2022. We analyzed common serological indicators in our hospital to identify predictive indicators for the early diagnosis of IPA in COPD patients.

Results: The sensitivity and specificity of C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), procalcitonin (PCT), lactate dehydrogenase (LDH), and ceruloplasmin (CER) for diagnosing IPA in COPD patients were as follows: CRP (91.2%, 57.7%), ESR (77.5%, 73.0%), PCT (60.5%, 71.4%), LDH (50.0%, 88.8%), and CER (60.7%, 74.3%). Combinations of biomarkers, such as CRP-ESR, CRP-LDH, ESR-LDH, ESR-CER, and LDH-CER, showed promising diagnostic potential, with larger area under the curve (AUC) values for IPA diagnosis in COPD patients. However, no statistically significant difference was observed between the diagnostic efficacy of single biomarkers and combined biomarkers. Notably, compared to those in the unassisted ventilation group, the patients in the assisted ventilation group (including noninvasive ventilation and tracheal intubation/incision-assisted ventilation group) exhibited significantly greater PCT and LDH levels, while the CER significantly decreased (p=0.021). There were no significant differences in biomarker levels between the ICU group and the non-ICU group. CRP (p<0.01), ESR (p=0.028), PCT (p<0.01), and CER (p<0.01) were positively correlated with hospitalization duration, whereas LDH was not correlated with hospitalization duration.

Conclusion: Our study highlights the diagnostic potential of CRP, ESR, PCT, LDH, and CER for IPA in COPD patients. CRP and LDH can also initially predict the need for assisted ventilation, while CRP can initially estimate the length of hospitalization. This study represents the first report of the potential of CER for diagnosing IPA, suggesting its significance for further research.

Keywords: C-reactive protein; ceruloplasmin; chronic obstructive pulmonary disease; erythrocyte sedimentation rate; invasive pulmonary aspergillosis; lactate dehydrogenase; procalcitonin.

MeSH terms

  • Biomarkers
  • C-Reactive Protein / analysis
  • Humans
  • Invasive Pulmonary Aspergillosis*
  • Procalcitonin
  • Pulmonary Disease, Chronic Obstructive*
  • Retrospective Studies

Substances

  • C-Reactive Protein
  • Biomarkers
  • Procalcitonin

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by grants from the National Natural Science Foundation of China (grant numbers NSFC 82370011, NSFC 82202544 and NSFC 82270007), the Guangdong Basic and Applied Basic Research Foundation (2022A1515010089), the Science and Technology Program of Guangzhou (202201020537/ZNSA-2020003), and the Guangzhou Science and Technology Plans (No. 202201020513), the Guangxi Natural Science Foundation (2021GXNSFBA220064) and the Open Project of the State Key Laboratory of Respiratory Diseases (SKLRD-OP-202210; SKLRD-OP-202102).